Riboldi, Piersandro

Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study

Fraticelli, P., Gabrielli, B., Pomponio, G., Valentini, G., Bosello, S., Riboldi, P., Gerosa, M., Faggioli, P., Giacomelli, R., Del Papa, N., et al. (2014) · Arthritis Research & Therapy

Systemic Sclerosis and Related DiseasesPulmonary Hypertension Research and Treatments

Cited by 108

Pathogenic mechanisms mediating antiphospholipid syndrome

Meroni, P. L., & Riboldi, P. (2001) · Current Opinion in Rheumatology

Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms

Cited by 99